CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

News and Events

Latest News

Announcing the Canadian Journal of Health Technologies – A New Journal From CADTH

April 22, 2021
A message from Suzanne McGurn, President and CEO of CADTH On behalf of the team at CADTH, I’m proud and excited to announce that we have launched the Canadian Journal of Health Technologies, a new open-access journal serving the Canadian and global health technology assessment (HTA) community. You can find it online at canjhealthtechnol.ca and ...

CADTH Recommends Gene Therapy for Infants With Rare Genetic Disorder

March 26, 2021
Onasemnogene abeparvovec (Zolgensma) is the first gene therapy used to treat spinal muscular atrophy — a rare progressive and life-threatening condition that often begins in childhood and is caused by a genetic mutation. Conditions for reimbursement include a price reduction and clinical criteria for initiating treatment. Today, CADTH recom...

Upcoming Events

CADTH In Conversation With…. Professor Gillian Leng CBE, Chief Executive of NICE

May 27, 2021
Join Suzanne McGurn, President and CEO of CADTH, as she welcomes Gillian Leng, CBE, for an insightful conversation on what the future holds for the United Kingdom’s influential National Institute for Health and Care Excellence, better known as NICE. REGISTER NOW Gillian will discuss NICE’s new 5-year strategic plan and how it will impact the a...

2021 CADTH Virtual Symposium

November 2, 2021 - November 4, 2021
The 2021 CADTH Symposium will be held online on November 2, 3, and 4. The theme is Uncertain Times, Imperfect Evidence, and the Imperative to Act.  Take this opportunity to connect with Canadian and international experts for three days of education, information sharing, and networking on the objective assessment and evaluation of heal...